Stephen V Liu, MD· @StephenVLiu · X·· 2026-04-19Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
Body
#AACR26 EFS prolonged with nivo regardless of ctDNA status (detectable at baseline, clearance before surgery, MRD status). Machine learning model associates EFS with ctDNA clearance, non-N2, squamous histology, and nivo treatment (but NOT KEAP1, SMARCA4, CDKN2A mt).
Heat 36 · 21 likes · 1 reply · 14 reposts
Source: Stephen V Liu, MD · x.com
